Characterization of two human IgM monoclonal antibodies reactive with HLA-B27. 1995

A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
Department of Transfusion Medicine, University of Ulm, Germany.

We describe here the generation and characterization of two human monoclonal IgM antibodies (UL-4F11 and UL-F6) reactive with HLA-B27. The monoclonal antibody (mAb) UL-4F11 is cytotoxic for peripheral mononuclear cells and, therefore, useful as typing reagent for HLA-B27 and HLA-B38. Protein chemistry showed that the mAb UL-4F11 precipitates HLA-B27 molecules. Epitope mapping analysis suggests that the amino acids 45, 67, 82 and 83 (alpha-1 domain) of the HLA-B27 sequence are necessary for mAb UL-4F11 reactivity. The mAb UL-F6 is suitable for complement dependent lysis of lymphoblastoid cell lines and stimulated peripheral blood mononuclear cells with HLA-B27 (B*2701, B*2702, B*2703, B*2705, B*2707), B13, B40 (60,61), B47 and B48 specificities. Its reactivity indicates that the amino acid valine in position 152 and glutamic acid in position 163 of the alpha-2 domain are crucial for the binding epitope.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
November 1983, British journal of rheumatology,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
November 1983, The Journal of rheumatology. Supplement,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
June 1992, European journal of immunology,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
November 1991, Tissue antigens,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
January 1983, Immunogenetics,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
April 1997, Scandinavian journal of immunology,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
March 1993, Human immunology,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
July 2003, Cytometry. Part B, Clinical cytometry,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
October 1997, Clinical chemistry,
A Wölpl, and A Toubert, and K Siemoneit, and T H Eiermann, and H Neumayer, and S F Goldmann
October 1983, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!